The US FDA continues to invite patients to help it better open its doors, potentially further enhancing their influence over drug reviews and clinical trial design.
Andrea Furia-Helms, health programs coordinator in the Office of Health and Constituent Affairs, said May 12 that a new group...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?